Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations | Molecular Cancer User montaukwhaler, in the non small cell lung cancer subreddit, 22 Sep 2019